Abstrakt

Przypisy

• 1. Akao Y., Nakagawa Y., Akiyama K.: Arsenic trioxide induces apoptosisin neuroblastoma cell lines through the activation of caspase 3 in vitro.FEBS Lett., 1999; 455: 59-62
  Google Scholar
• 2. Aplin A., Jasionowski T., Tuttle D.L., Lenk S., Dunn W.A.Jr.: Cytoskeletalelements are required for the formation and maturation of autophagicvacuoles. J. Cell Physiol., 1992; 153: 458-466
  Google Scholar
• 3. Barth S., Glick D., Macleod K.F.: Autophagy: assays and artifacts. JPathol., 2010; 221: 117-124
  Google Scholar
• 4. Binet F., Cavalli H., Moisan E., Girard D.: Arsenic trioxide (AT) is anovel human neutrophil pro-apoptotic agent: effects of catalase onAT-induced apoptosis, degradation cytoskeletal proteins and de novoprotein synthesis. Br. J. Haematol., 2006; 132: 349-358
  Google Scholar
• 5. Bode A.M., Dong Z.: The paradox of arsenic: molecular mechanismsof cell transformation and chemotherapeutic effects. Crit. Rev. Oncol.Hematol., 2002; 42: 5-24
  Google Scholar
• 6. Bolt A.M., Byrd R.M., Klimecki W.T.: Autophagy is the predominantprocess induced by arsenite in human lymphoblastoid cell lines. Toxicol.Appl. Pharmacol., 2010; 244: 366-373
  Google Scholar
• 7. Bonfoco E., Leist M., Zhivotovsky B., Orrenius S., Lipton S.A., NicoteraP.: Cytoskeletal breakdown and apoptosis elicited by NO donors incerebellar granule cells require NMDA receptor activation. J. Neurochem.,1996; 67: 2484-2493
  Google Scholar
• 8. Brown S.B., Bailley K., Savill J.: Actin is cleaved during constitutiveapoptosis. Biochem. J., 1996; 323: 233-237
  Google Scholar
• 9. Bursch W., Hochegger K., Török L., Marian B., Ellinger A., HermannR.S.: Autophagic and apoptotic types of programmed cell death exhibitdifferent fates of cytoskeletal filaments. J. Cell Sci., 2000; 113:1189-1198
  Google Scholar
• 10. Carney D.A.: Arsenic trioxide mechanisms of action – looking beyondacute promyelocytic leukemia. Leuk. Lymphoma, 2008; 49: 1846-1851
  Google Scholar
• 11. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R.,Kroemer G.: Cell death by mitotic catastrophe: a molecular definition.Oncogene, 2004; 23: 2825-2837
  Google Scholar
• 12. Cha Y., Park D.W., Lee C.H., Baek S.H., Kim S.Y., Kim J.R., Kim J.H.:Arsenic trioxide induces apoptosis in human colorectal adenocarcinomaHT-29 cells through ROS. Cancer Res. Treat., 2006; 38: 54-60
  Google Scholar
• 13. Charoensuk V., Gati W.P., Weinfeld M., Le X.C.: Differential cytotoxiceffects of arsenic compounds in human acute promyelocytic leukemiacells. Toxicol. Appl. Pharmacol., 2009; 239: 64-70
  Google Scholar
• 14. Chen G.Q., Zhu J., Shi X.G., Ni J.H., Zhong H.J., Si G.Y., Jin X.L., TangW., Li X.S., Xong S.M., Shen Z.X., Sun G.L., Ma J., Zhang P., Zhang T.D.,Gazin C., Naoe T., Chen S.J., Wang Z.Y., Chen Z.: In vitro studies on cellularand molecular mechanisms of arsenic trioxide (As2O3) in the treatmentof acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosiswithdown regulation of Bcl-2 expression and modulation of PML-RAR α/PML proteins. Blood, 1996; 88: 1052-1061
  Google Scholar
• 15. Chen M.J., Yang P.Y., Ye Y.Z., Hu D.N., Chen M.F.: Arsenic trioxideinduces apoptosis in uveal melanoma cells through the mitochondrialpathway. Am J. Chin. Med., 2010; 38: 1131-1142
  Google Scholar
• 16. De Bruin E.C., Medema J.P.: Apoptosis and nonapoptotic deathsin cancer development and treatment response. Cancer Treat. Rev.,2008; 34: 737-749
  Google Scholar
• 17. Desouza M., Gunning P.W., Stehn J.R.: The actin cytoskeleton as asensor and mediator of apoptosis. BioArchitecture, 2012; 2: 75-87
  Google Scholar
• 18. Dong Z.: The molecular mechanisms of arsenic-induced cell transformationand apoptosis. Environ. Health Perspect., 2002; 110, Suppl.5: 757-759
  Google Scholar
• 19. Erenpreisa J., Cragg M.S.: Mitotic death: a mechanism of survival?A review. Cancer Cell Int., 2001; 1: 1
  Google Scholar
• 20. Evens A.M., Tallman M.S., Gartenhaus R.B.: The potential of arsenictrioxide in the treatment of malignant disease: past, present, and future.Leukemia Res., 2004; 28: 891-900
  Google Scholar
• 21. Fengsrud M., Roos N., Berg T., Liou W.L., Slot J.W., Seglen P.O.: Ultrastructuraland immunocytochemical characterization of autophagicvacuoles in isolated hepatocytes: effects of vinblastine and asparagineon vacuole distributions. Exp. Cell Res., 1995; 221: 504-519
  Google Scholar
• 22. Gonçalvesa A.P., Máximo V., Limac J., Singhe K.K., Soares P., VideiraA.: Involvement of p53 in cell death following cell cycle arrest and mitoticcatastrophe induced by rotenone. Biochim. Biophys. Acta, 2011;1813: 492-499
  Google Scholar
• 23. Grzanka A., GrzankaD., Orlikowska M.: Cytoskeletal reorganizationduring process of apoptosis induced by cytostatic drugs in K-562 andHL-60 leukemia cell lines. Biochem. Pharmacol., 2003; 66: 1611-1617
  Google Scholar
• 24. Grzanka A., Grzanka D., Orlikowska M.: Fluorescence and ultrastructurallocalization of actin distribution patterns in the nucleusof HL-60 and K-562 cell lines treated with cytostatic drugs. Oncol.Rep., 2004; 11: 765-770
  Google Scholar
• 25. Grzanka D., Grzanka A., Izdebska M., Gackowska L., Stepien A.,Marszalek A.: Actin reorganization in CHO AA8 cells undergoingmitotic catastrophe and apoptosis induced by doxorubicin. OncolRep., 2010; 23: 655-663
  Google Scholar
• 26. Høyvik H., Gordon P.B., Berg T.O., Strømhaug P.E., Seglen P.O.:Inhibition of autophagiclysosomal delivery and autophagic lactolysisby asparagine. J. Cell Biol., 1991; 113: 1305-1312
  Google Scholar
• 27. Huang C., Ma W.Y., Li J., Dong Z.: Arsenic induces apoptosisthrough a c-Jun NH2-terminal kinase-dependent, p53-independentpathway. Cancer Res., 1999; 59: 3053-3058
  Google Scholar
• 28. Ianzini F., Bertoldo A., Gesie A., Kosmacek E.A., Nguyen T., MackeyM.A.: Adriamycin induces mitotic catastrophe in PC-3 humanprostate cancer cells. 51st Annual Meeting of the Radiation ResearchSociety. St. Louis, MO, April 24-27, 2004
  Google Scholar
• 29. Ianzini F., Bertoldo A., Kosmacek E.A., Phillips S.T., Mackey M.A.:Lack of p53 function promotes radiation-induced mitotic catastrophein mouse embryonic fibroblast cells. Cancer Cell Int., 2006; 6: 11
  Google Scholar
• 30. Ianzini F., Mackey M.A.: Spontaneous premature chromosomecondensation and mitotic catastrophe following irradiation of HeLaS3 cells. Intl. J. Radiat. Biol., 1997; 72: 409-421
  Google Scholar
• 31. Izdebska M., Grzanka A., Ostrowski M., Żuryń A., Grzanka D.:Effect of arsenic trioxide (Trisenox) on actin organization in K-562erythroleukemia cells. Folia Histochem. Cytobiol., 2009; 47: 453-459
  Google Scholar
• 32. Izdebska M., Grzanka D., Gackowska L., Żuryń A., Grzanka A.:The influence of Trisenox on actin organization in HL-60 cells. Cent.Eur. J. Biol., 2009; 4: 351-361
  Google Scholar
• 33. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., Waxman S.:Arsenic trioxide selectively induces acute promyelocytic leukemiacell apoptosis via a hydrogen peroxide-dependent pathway. Blood,1999; 94: 2102-2111
  Google Scholar
• 34. Kanzawa T., Kondo Y., Ito H., Kondo S., Germano I.: Induction ofautophagic cell death in malignant glioma cells by arsenic trioxide.Cancer Res., 2003; 63: 2103-2108
  Google Scholar
• 35. Klimaszewska A., Izdebska M., Gagat M., Grzanka D., GrzankaA.: The influence of arsenic trioxide on the reorganization of thetubulin protein in CHO AA8 cell line. Med. Biol. Sci., 2011; 25: 17-23
  Google Scholar
• 36. Kondo Y., Kanzawa T., Sawaya R., Kondo S.: The role of autophagyin cancer development and response to therapy. Nat. Rev. Cancer,2005; 5: 726-734
  Google Scholar
• 37. Li W., Chou I.N.: Effects of sodium arsenite on the cytoskeletonand cellular glutathione levels in cultured cells. Toxicol. Appl. Pharmacol.,1992; 114: 132-139
  Google Scholar
• 38. Li Y.M., Broome J.D.: Arsenic targets tubulins to induce apoptosisin myeloid leukemia cells. Cancer Res., 1999; 59: 776-780
  Google Scholar
• 39. Menzel D.B., Hamadeh H.K., Lee E., Meacher D.M., Said V., RasmussenR.E., Greene H., Roth R.N.: Arsenic binding proteins fromhuman lymphoblastoid cells. Toxicol. Lett., 1999; 105: 89-101
  Google Scholar
• 40. Miller W.H., Hyman M., Schiooer M., Lee J.S., Singer J., WaxmanS.: Mechanism of action of arsenic trioxide. Cancer Res., 2002;62: 3893-3903
  Google Scholar
• 41. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C.:A rapid and simple method for measuring thymocyte apoptosis bypropidium iodide staining and flow cytometer. J. Immunol. Methods,1991; 139: 271-276
  Google Scholar
• 42. Nowak J.M., Grzanka A., Gagat M., Żuryń A.: The influence ofcotinine on the non-small-cell lung cancer line A549. Postępy Hig.Med. Dośw., 2009; 63: 1-7
  Google Scholar
• 43. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M.,Sphicas E., Domingo D., Yahalom J.: A novel response of cancer cellsto radiation involves autophagy and formation of acidic vesicles.Cancer Res., 2001; 61: 439-444
  Google Scholar
• 44. Pettersson H.M., Pietras A., Munksgaard Persson M., KarlssonJ., Johansson L., Shoshan M.C. Påhlman S.: Arsenic trioxide is highlycytotoxic to small cell lung carcinoma cells. Mol. Cancer Ther.,2009; 8: 160-170
  Google Scholar
• 45. Portugal J., Mansilla S., Bataller M.: Mechanisms of drug-inducedmitotic catastrophe in cancer cells. Curr. Pharm. Des., 2010; 16: 69-78
  Google Scholar
• 46. Qian W., Liu J., Jin J., Ni W., Xu W.: Arsenic trioxide induces notonly apoptosis but also autophagic cell death in leukemia cell linesvia up-regulation of Beclin-1. Leuk. Res., 2007; 31: 329-339
  Google Scholar
• 47. Ricci M.S., Zong W.X.: Chemotherapeutic approaches for targetingcell death pathways. The Oncologist, 2006; 11: 342-357
  Google Scholar
• 48. Roninson I.B., Broude E.V., Chang B.D.: If not apoptosis, thenwhat? Treatment-induced senescence and mitotic catastrophe intumor cells. Drug Resist. Update, 2001; 4: 303-313
  Google Scholar
• 49. Shen Z.Y., Shen J., Cai W.J., Hong C., Zheng M.H.: The alterationof mitochondria is an early event of arsenic trioxide-induced apoptosisin esophageal carcinoma cells. Int. J. Mol. Med., 2000; 5: 155-158
  Google Scholar
• 50. Shim M.J., Kim H.J., Yang S.J., Lee I.S., Choi H.I., Kim T.: Arsenictrioxide induces apoptosis in chronic myelogenous leukemia K562cells: possible involvement of p38 MAP kinase. Biochem. Mol. Biol.,2002; 35: 377-383
  Google Scholar
• 51. Stankiewicz M., Jonas W., Hadas E., Cabaj W., Douch P.G.: Supravitalstaining of eosinophils. Int. J. Parasitol., 1996; 26: 445-446
  Google Scholar
• 52. Taylor B.F., McNeely S.C., Miller H.L., Lehmann G.M., McCabeM.J.Jr., States J.C.: p53 suppression of arsenite-induced mitoticcatastrophe is mediated by p21CIP1/WAF1. J. Pharmacol. Exp. Ther.,2006; 318: 142-151
  Google Scholar
• 53. Taylor B.F., McNeely S.C., Miller H.L., States J.C.: Arsenite-inducedmitotic death involves stress response and is independent oftubulin polymerization. Toxicol. Appl. Pharmacol., 2008; 230: 235-246
  Google Scholar
• 54. Traganos F., Darzynkiewicz Z.: Lysosomal proton pump activity:supravital cell staining with acridine orange differentiates leukocytesubpopulations. Methods Cell Biol., 1994; 41: 185-194
  Google Scholar
• 55. Uslu R., Sanli U.A., Sezgin C., Karabulut B., Terzioglu E., OmayS.B., Goker E.: Arsenic trioxide-mediated cytotoxicity and apoptosisin prostate and ovarian carcinoma cell lines. Clin. Cancer Res.,2000; 6: 4957-4964
  Google Scholar
• 56. Wang Y., Zhang Y., Yang L., Cai B., Li J., Zhou Y., Yin L., Yang L.,Yang B.F., Lu Y.: Arsenic trioxide induces the apoptosis of human breastcancer MCF-7 cells through activation of caspase-3 and inhibitionof HERG channels. Exp. Ther. Med., 2011; 2: 481-486
  Google Scholar
• 57. Waxman S., Anderson K.C.: History of the development of arsenicderivatives in cancer therapy. Oncologist, 2001; 6: 3-10
  Google Scholar
• 58. Yih L.H., Ho I.C., Lee T.C.: Sodium arsenite disturbs mitosis andinduces chromosome loss in human fibroblasts. Cancer Res., 1997;57: 5051-5059
  Google Scholar
• 59. Yih L.H., Tseng Y.Y., Wu Y.C., Lee T.C.: Induction of centrosomeamplification during arsenite-induced mitotic arrest in CGL-2 cells.Cancer Res., 2006; 66: 2098-2106
  Google Scholar
• 60. Zhang G., Gurtu V., Kain S.R. Yan G.: Early detection of apoptosisusing a fluorescent conjugate of annexin V. BioTechniques,1997; 23: 525-531
  Google Scholar
• 61. Zitterbart K., Veselská R.: Effect of retinoic acid on the actin cytoskeletonin HL-60 cells. Neoplasma, 2001; 48: 456-461
  Google Scholar

Pełna treść artykułu